Literature DB >> 9167768

Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer.

K Rembrink1, J C Romijn, T H van der Kwast, H Rübben, F H Schröder.   

Abstract

BACKGROUND: To study the metastatic behavior of human prostate cancer cell lines, orthotopic injection in nude mice was performed.
METHODS: Local tumor growth, metastasis formation, prostate-specific antigen, and androgen receptor expression were examined.
RESULTS: Hormone-independent cell lines (PC-3, PC-3-125-IL, and TSU-Pr1) were highly tumorigenic and had a higher rate of lymph node metastasis after orthotopic than after subcutaneous implantation. PC-3 cell lines also consistently metastasized to the lungs. The androgen-sensitive LNCaP cell line showed local growth in 7 of 10, and lymph node metastasis in 4 animals. Significant serum PSA levels and strong receptor expression in primary and metastatic tumor tissues were observed.
CONCLUSIONS: These results demonstrates that orthotopic implantation of human prostate cancer cell lines, including LNCaP, reproducibly leads to metastasis formation in nude mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9167768     DOI: 10.1002/(sici)1097-0045(19970515)31:3<168::aid-pros4>3.0.co;2-h

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  23 in total

Review 1.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

2.  Suppressive roles of calreticulin in prostate cancer growth and metastasis.

Authors:  Mahesh Alur; Minh M Nguyen; Scott E Eggener; Feng Jiang; Soheil S Dadras; Jeffrey Stern; Simon Kimm; Kim Roehl; James Kozlowski; Michael Pins; Marek Michalak; Rajiv Dhir; Zhou Wang
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

3.  Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.

Authors:  Peter Jantscheff; Vittorio Ziroli; Norbert Esser; Ralph Graeser; Jessica Kluth; Alena Sukolinskaya; Lenka A Taylor; Clemens Unger; Ulrich Massing
Journal:  Clin Exp Metastasis       Date:  2009-09-26       Impact factor: 5.150

4.  Efficacy of c-Met inhibitor for advanced prostate cancer.

Authors:  William H Tu; Chunfang Zhu; Curtis Clark; James G Christensen; Zijie Sun
Journal:  BMC Cancer       Date:  2010-10-14       Impact factor: 4.430

5.  Study of protoporphyrin IX elimination by body excreta: a new noninvasive cancer diagnostic method?

Authors:  Flávia R O Silva; Camila T Nabeshima; Maria H Bellini; Nestor Schor; Nilson D Vieira; Lilia C Courrol
Journal:  J Fluoresc       Date:  2012-09-09       Impact factor: 2.217

6.  TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.

Authors:  Elizabeth C Wayne; Siddarth Chandrasekaran; Michael J Mitchell; Maxine F Chan; Rachel E Lee; Chris B Schaffer; Michael R King
Journal:  J Control Release       Date:  2015-12-28       Impact factor: 9.776

7.  Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.

Authors:  Hannes Steiner; Sonia Godoy-Tundidor; Hermann Rogatsch; Andreas P Berger; Dietmar Fuchs; Barbara Comuzzi; Georg Bartsch; Alfred Hobisch; Zoran Culig
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

8.  Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo.

Authors:  Yue-Feng Du; Ying Shi; Yi-Fei Xing; Yi-fei Xing; Fu-Qing Zeng; Fu-qing Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-23       Impact factor: 4.553

9.  Pre-clinical Orthotopic Murine Model of Human Prostate Cancer.

Authors:  Varahram Shahryari; Hannah Nip; Sharanjot Saini; Altaf A Dar; Soichiro Yamamura; Yozo Mitsui; Melissa Colden; Nathan Bucay; Laura Z Tabatabai; Kirsten Greene; Guoren Deng; Yuichiro Tanaka; Rajvir Dahiya; Shahana Majid
Journal:  J Vis Exp       Date:  2016-08-29       Impact factor: 1.355

Review 10.  Calcium-sensing receptor in cancer: good cop or bad cop?

Authors:  Bandana Chakravarti; Shailendra Kumar Dhar Dwivedi; Ambrish Mithal; Naibedya Chattopadhyay
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.